Pro-inflammatory diets associated with worse outcomes for stage III colon cancer

Exercise programme may lower risk of recurrence and death for some colon cancer survivors

CtDNA useful biomarker for muscle-invasive bladder cancer patients who received perioperative durvalumab

Sasanlimab BCG combo improves outcomes in high-risk NMIBC

Oral paclitaxel shows non-inferior efficacy compared to IV paclitaxel for HER2-negative mBC

Adjuvant temozolomide improves survival in IDH-mutant anaplastic glioma

Neoadjuvant PD-1 blockade enables organ preservation in early dMMR tumours without surgery

CtDNA monitoring of ER+/HER2- breast cancer during adjuvant endocrine therapy shows promise

Vepdegestrant could extend PFS for some ESR1-mutated advanced breast cancers

Olaparib boosts chemotherapy’s impact on BRCA-mutated breast cancer

Managing gastrotoxicities for RCC treatment – Gastroenterologist's perspective

WRN inhibitor shows promise in patients with MSI and/or dMMR advanced solid tumours